Depressive Disorders

116 questions

Question 81Question →

A 32-year-old woman presents to the outpatient clinic with a 2-month history of severely depressed mood. She reports sleeping up to 14 hours a day, an increased appetite with a 5-kg (11-lb) weight gain, and a frequent sensation that her arms and legs are "made of lead." She states that she briefly feels better when her friends visit, but her low mood quickly returns. She has no prior psychiatric history and has never been treated for depression. She tearfully requests an antidepressant medication so she can return to her job as an accountant. Her vital signs and physical examination are unremarkable. Laboratory studies reveal a thyroid-stimulating hormone (TSH) level of 1.5 mU/L (normal: 0.4-4.0 mU/L) and a free T4 at the lower limit of normal. A urine toxicology screen is negative. The physician diagnoses a major depressive episode with atypical features and considers initiating pharmacotherapy. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Elicit a history of periods of elevated mood, impulsivity, and decreased need for sleep

Answer

The correct answer is to elicit a history of periods of elevated mood, impulsivity, and decreased need for sleep.
The correct next step is to screen the patient for a lifetime history of manic or hypomanic episodes. While this patient is currently experiencing a major depressive episode, atypical features (such as hypersomnia, weight gain, leaden paralysis, and mood reactivity) are particularly common in the depressive phase of bipolar disorder. Universal screening for bipolar disorder is required before initiating any antidepressant monotherapy. Failing to do so can lead to the inappropriate administration of an antidepressant (e.g., an SSRI), which carries a significant risk of inducing a manic switch or rapid cycling in patients with underlying bipolar disorder.

Step-by-Step Solution

1
Identify the current clinical syndrome.
The patient meets the criteria for a major depressive episode with atypical features (hypersomnia, hyperphagia, leaden paralysis, mood reactivity).
Recognizing the symptom cluster is required to establish the baseline diagnosis.
2
Determine the necessary safety and diagnostic checks prior to initiating antidepressant treatment.
The physician must screen for a history of mania or hypomania.
Antidepressant monotherapy can precipitate a manic episode (manic switch) in patients with undiagnosed bipolar disorder. Atypical depressive features specifically have a high correlation with bipolar depression.
3
Evaluate the provided options against standard psychiatric management guidelines.
Screening for manic/hypomanic symptoms is the only safe and appropriate next step before writing a prescription.
All other options involve inappropriate prescribing practices, contraindicated combinations, or incorrect application of diagnostic timelines.

Key Concept

Screening for bipolar disorder before initiating antidepressant monotherapy
Question 82Question →

A 28-year-old woman comes to the outpatient clinic for a follow-up appointment. Three weeks ago, she presented with a 2-month history of pervasive sadness, sleeping 14 hours a day, a significantly increased appetite, and a sensation that her arms and legs were "weighed down by lead." She was diagnosed with major depressive disorder and prescribed sertraline. Today, she reports no improvement in her mood or energy. She states, "I have been taking these pills for three weeks and feel exactly the same; I want to just stop taking them."

Upon further questioning, the patient describes an episode three years ago that lasted for two weeks. During that time, she felt "invincible," slept only 2 hours a night without feeling fatigued, spoke so rapidly that friends could not follow her thoughts, and impulsively bought a luxury car she could not afford, which subsequently led to bankruptcy. She has never been hospitalized for psychiatric reasons. Vital signs and physical examination are normal.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue sertraline and initiate quetiapine

Answer

The correct management is to discontinue sertraline and initiate quetiapine.
The correct answer is to discontinue the offending SSRI and initiate an appropriate treatment for bipolar depression. This patient presents with a depressive episode featuring atypical symptoms. However, her history of a two-week period characterized by grandiosity, decreased sleep, rapid speech, and severe financial impairment perfectly describes a manic episode. This establishes a diagnosis of Bipolar I Disorder. The use of antidepressant monotherapy (such as sertraline) is contraindicated in bipolar disorder due to the high risk of precipitating a manic switch. The best next step is to discontinue the sertraline and start a first-line agent for acute bipolar depression, such as the atypical antipsychotic quetiapine, or lurasidone.

Step-by-Step Solution

1
Analyze the patient's current symptoms and psychiatric history.
The patient is currently experiencing a depressive episode with atypical features (hypersomnia, hyperphagia, leaden paralysis). However, she has a history of a 2-week episode of grandiosity, decreased need for sleep, pressured speech, and severe impairment (bankruptcy).
Identifying past manic episodes is essential to distinguish Major Depressive Disorder from Bipolar I Disorder.
2
Determine the correct psychiatric diagnosis.
The history of a full manic episode changes the diagnosis from Major Depressive Disorder to Bipolar I Disorder, most recent episode depressed.
A single manic episode is sufficient to establish a diagnosis of Bipolar I Disorder, regardless of current symptoms.
3
Evaluate the current treatment regimen and determine the best next step.
The patient is currently taking sertraline, an SSRI, as monotherapy. This is contraindicated in bipolar disorder and must be stopped. A medication approved for acute bipolar depression, such as quetiapine, should be initiated.
Antidepressant monotherapy in bipolar disorder risks precipitating a manic switch. Quetiapine is a first-line treatment for acute bipolar depression.

Key Concept

Antidepressant monotherapy is contraindicated in patients with Bipolar Disorder due to the risk of inducing a manic switch. Patients presenting with a depressive episode must be thoroughly screened for a history of mania or hypomania before initiating antidepressants.
Question 83Question →

Accompanied by his roommate, a 21-year-old male college student is brought to the university counseling and psychiatric emergency center. Three weeks ago, he was evaluated at a local walk-in clinic for a two-month history of profound low mood, sleeping up to 14 hours a day, intense cravings for sugary foods, and a sensation that his arms were excessively heavy. At that time, he was diagnosed with major depressive disorder and prescribed fluoxetine. Today, the roommate reports a drastic change in the patient's behavior over the past four days. The patient is currently pacing the examination room, speaking rapidly, and excitedly explaining that he has discovered a theoretical formula that will solve global energy shortages. He mentions he has only slept for two hours over the past two days but feels 'more energetic than ever.' Medical history is otherwise unremarkable. Vital signs are within normal limits. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Discontinue the current medication and initiate a mood-stabilizing atypical antipsychotic

Answer

Discontinue the current medication and initiate a mood-stabilizing atypical antipsychotic
This patient is presenting with an acute manic episode, characterized by a decreased need for sleep, pressured speech, psychomotor agitation, and grandiose delusions. This episode was likely precipitated by the initiation of fluoxetine. The patient's initial presentation of atypical depression (hypersomnia, hyperphagia, leaden paralysis) carries a higher risk of underlying bipolarity. The most appropriate immediate step in management is to discontinue the offending antidepressant, which is fueling the mania, and simultaneously initiate an antimanic medication, such as a mood-stabilizing atypical antipsychotic (e.g., quetiapine, olanzapine) to rapidly control the acute symptoms.

Step-by-Step Solution

1
Analyze the patient's initial presentation and current symptoms.
The patient initially presented with symptoms of atypical depression and was prescribed an SSRI. He now presents with a decreased need for sleep, pressured speech, pacing, and grandiose delusions.
Establishing a clinical timeline is necessary to determine the cause of the sudden behavioral change.
2
Identify the new clinical syndrome.
The patient is experiencing an acute manic episode, likely antidepressant-induced.
SSRI monotherapy in patients with unrecognized bipolar disorder (often presenting initially with atypical features) can trigger a manic switch.
3
Determine the most appropriate next step in management.
The offending SSRI must be discontinued, and an antimanic agent should be initiated.
Continuing the precipitating agent worsens mania, and acute mania requires immediate pharmacologic intervention.

Key Concept

Patients presenting with atypical depression are at a higher risk for underlying bipolar disorder. Initiation of an SSRI without a mood stabilizer in these patients can precipitate an acute manic episode, which requires immediate discontinuation of the antidepressant and initiation of an antimanic agent.
Question 84Question →

A 41-year-old man presents to the clinic with persistent low mood, anhedonia, and insomnia that have significantly impaired his ability to perform his job. He is diagnosed with major depressive disorder (MDD). He has no prior psychiatric history, no history of hypomanic or manic episodes, and no acute suicidal ideation. He expresses a preference for pharmacological treatment. Assuming the patient experiences inadequate clinical improvement at each successive stage of treatment, arrange the following management steps in the correct chronological sequence according to standard stepped-care guidelines for MDD.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of steps for escalating care in major depressive disorder is: (1) Initiate SSRI monotherapy, (2) Titrate to maximum tolerated dosage, (3) Augment with an atypical antipsychotic or second agent, and (4) Refer for neuromodulation therapies such as ECT.
The correct sequence follows the standard consensus guidelines (such as the APA practice guidelines) for treating major depressive disorder: initiating a well-tolerated first-line agent (SSRI), optimizing the dose if partial response is observed, employing augmentation or switching strategies for treatment-resistant cases failing a maximized trial, and finally utilizing neuromodulation (ECT) for refractory treatment-resistant depression.

Step-by-Step Solution

1
Identify the appropriate initial management for an uncomplicated first episode of MDD.
Initiate SSRI monotherapy.
SSRIs are the preferred first-line pharmacological treatment due to an optimal balance of safety, tolerability, and efficacy.
2
Determine the next step for a patient showing partial response after an initial 4-6 week trial.
Optimize the SSRI dosage.
Dose titration is indicated before switching or augmenting if the patient demonstrates partial improvement and is tolerating the medication well.
3
Select the intervention for a patient failing optimized monotherapy.
Augment with a second agent or switch classes.
Adding an atypical antipsychotic (or switching to an SNRI/TCA) addresses non-response to a maximized first-line agent, utilizing different neurochemical pathways.
4
Identify the management strategy for definitive treatment-resistant depression.
Refer for neuromodulation (ECT or TMS).
ECT and TMS are highly efficacious and indicated after multiple failed adequate medication trials or for urgent, severe presentations.

Key Concept

The stepped-care algorithm for Major Depressive Disorder prioritizes starting with a single, tolerable agent, optimizing its dose, sequentially moving to combinations/switching, and reserving neuromodulation for treatment resistance.
Question 85Question →

For each of the following patients presenting with depressed mood, select the most appropriate initial or next-step intervention based on their specific clinical diagnosis.

Click a left item, then click its matching right item

Items

A 24-year-old woman presenting with a 6-week history of severe depressed mood and hypersomnia. Review of systems reveals a distinct 5-day period last year involving decreased sleep and impulsive spending. She currently takes no medications.
A 71-year-old man with major depressive disorder who expresses a fixed delusion that his organs are decaying. He has refused all oral intake for four days, resulting in acute kidney injury and hemodynamic instability.
A 45-year-old woman presenting with a 6-week history of tearfulness and difficulty concentrating that began days after an unexpected divorce. She experiences reactivity of mood and does not meet full criteria for a major depressive episode.
A 60-year-old man presenting with new-onset pervasive sadness, anhedonia, and insomnia. These symptoms began two weeks after starting high-dose prednisone for giant cell arteritis. He has no prior psychiatric history.

Matches

Show answer & explanation

Answer

The correct matches pair bipolar II depression with quetiapine, life-threatening psychotic depression with urgent ECT, adjustment disorder with psychotherapy, and medication-induced depression with tapering the offending corticosteroid.
Each depressive syndrome requires precise identification to select the optimal intervention. Bipolar depression requires mood stabilization, severe psychotic depression with medical compromise requires ECT, adjustment disorder is treated with psychotherapy, and medication-induced depression is managed by modifying the offending agent.

Step-by-Step Solution

1
Analyze each patient's clinical history to differentiate the specific etiology of their depressed mood.
Patient 1 has bipolar II depression; Patient 2 has unipolar psychotic depression with medical emergency; Patient 3 has an adjustment disorder; Patient 4 has substance/medication-induced depressive disorder.
Accurate diagnosis among the differential for depressed mood is required before selecting an intervention.
2
Match the specific psychiatric diagnosis to its optimal evidence-based management strategy.
Bipolar depression warrants an atypical antipsychotic (quetiapine). Medically compromised psychotic depression requires rapid somatic therapy (ECT). Adjustment disorder is primarily treated with psychotherapy. Medication-induced mood changes are managed by dose reduction.
To ensure the intervention directly targets the underlying pathophysiology while minimizing the risk of adverse outcomes (e.g., manic switch, worsening renal failure).

Key Concept

The management of depressed mood requires differentiating unipolar major depressive disorder from bipolar depression, adjustment disorder, and substance-induced mood disorders, as each has distinct treatment pathways.
Estimated Time:1m 30s
Question 86Question →

A 28-year-old woman is brought to the outpatient clinic by her husband for evaluation of abnormal behavior and low mood. For the past 10 weeks, she has exhibited profound sadness, extreme fatigue, and hypersomnia, often sleeping 14 hours a day. Her husband reports that for the last 6 weeks, she has been responding to unseen stimuli and admits to hearing a persistent voice calling her a "worthless failure."

Two years ago, the patient experienced a 2-week episode of euphoric mood, boundless energy, and rapid speech. During that time, she slept only 2 hours a night and spent the couple's entire savings on unneeded luxury goods, which required a brief psychiatric hospitalization.

She currently takes no medications but asks if she can be started on a combination of a selective serotonin reuptake inhibitor (SSRI) and a monoamine oxidase inhibitor (MAOI), as she read online that this combination is highly effective for severe depression.

Laboratory evaluation shows:
Thyroid-stimulating hormone (TSH): 1.8 µU/mL (Normal: 0.5-5.0 µU/mL)
Free thyroxine (T4): 0.5 ng/dL (Normal: 0.9-1.7 ng/dL)

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate quetiapine monotherapy

Answer

Initiate quetiapine monotherapy
The correct action is to initiate quetiapine monotherapy. This patient has Bipolar I disorder, as evidenced by her past manic episode (euphoria, decreased sleep, impulsivity requiring hospitalization). She is currently experiencing a major depressive episode with psychotic features (sadness, hypersomnia, and auditory hallucinations). Quetiapine is a second-generation (atypical) antipsychotic with proven efficacy as monotherapy for bipolar depression. It is particularly appropriate in this case as it simultaneously treats the depressive mood symptoms and the psychotic symptoms without the risk of inducing a manic switch.

Step-by-Step Solution

1
Identify the current clinical syndrome.
The patient has a 10-week history of severe depression with 6 weeks of auditory hallucinations, indicating a major depressive episode with psychotic features.
Accurate characterization of the current episode is required to guide treatment.
2
Review the patient's past psychiatric history.
The patient had a distinct 2-week episode of euphoria, decreased need for sleep, and impulsivity requiring hospitalization, which meets the criteria for a manic episode.
A history of mania changes the diagnosis from Major Depressive Disorder to Bipolar I Disorder.
3
Select the appropriate pharmacotherapy.
Quetiapine monotherapy is selected.
Atypical antipsychotics such as quetiapine are first-line treatments for bipolar depression with psychotic features, as they avoid the risk of antidepressant-induced manic switching.

Key Concept

Patients presenting with depressive episodes must be screened for a history of mania to differentiate unipolar depression from bipolar disorder; bipolar depression is treated with mood stabilizers or specific atypical antipsychotics to avoid inducing a manic episode.
Question 87Question →

A 35-year-old woman is brought to the clinic by her husband for a follow-up appointment. Two weeks ago, she was prescribed sertraline 50 mg daily for a 2-month history of pervasive sadness, sleeping 12 hours a day, a heavy sensation in her extremities, and a 10-lb weight gain following the sudden death of her father. Today, she reports no improvement in her mood and asks to stop the antidepressant because "two weeks is long enough to know it is not working."

She has a history of a pituitary microadenoma treated with transsphenoidal resection 3 years ago, for which she takes levothyroxine. She also takes a daily over-the-counter St. John's wort supplement. Upon further questioning, her husband notes that during college, the patient had a distinct 6-day period where she slept only 2 hours a night, spoke extremely rapidly, and maxed out her credit cards. She also mentions hearing her deceased father's voice calling her name once a few days ago.

Vital signs are within normal limits. Laboratory studies show:

TestResultReference Range
Thyroid-stimulating hormone (TSH)0.2 µU/mL0.4-4.0 µU/mL
Free thyroxine (T4)0.6 ng/dL0.9-1.7 ng/dL

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Cross-taper sertraline to quetiapine and discontinue St. John's wort

Answer

Cross-taper sertraline to quetiapine and discontinue St. John's wort
The patient's presentation of a major depressive episode combined with a history of a distinct hypomanic episode (lasting at least 4 days with decreased need for sleep, rapid speech, and impulsivity) establishes a diagnosis of Bipolar II disorder. In bipolar depression, SSRI monotherapy is contraindicated due to the risk of inducing a manic switch. The most appropriate pharmacotherapy includes withdrawing the SSRI and initiating a medication approved for bipolar depression, such as quetiapine. Furthermore, St. John's wort must be discontinued because its concurrent use with an SSRI poses a significant risk for serotonin syndrome, and as a CYP3A4 inducer, it would subtherapeutically lower quetiapine levels.

Step-by-Step Solution

1
Evaluate the patient's psychiatric history to establish a correct diagnosis.
The patient has a current major depressive episode with atypical features, plus a history of a 6-day hypomanic episode (decreased sleep, rapid speech, impulsivity). This confirms a diagnosis of Bipolar II disorder.
Differentiating unipolar from bipolar depression is critical before managing antidepressant therapy.
2
Assess the safety of the current pharmacologic regimen.
The patient is on an SSRI (sertraline) and St. John's wort. This combination poses a high risk for serotonin syndrome.
Both agents possess strong serotonergic activity and must not be used concurrently.
3
Determine the appropriate psychopharmacological intervention.
SSRI monotherapy is contraindicated in bipolar depression due to the risk of mood destabilization. A transition to an approved bipolar depression agent (e.g., quetiapine, lurasidone) is required.
Although the patient wants to stop the drug prematurely due to 'lack of efficacy' at 2 weeks, stopping it is actually the correct medical decision due to the bipolar diagnosis and interaction risks.
4
Interpret the thyroid function tests in the context of her surgical history.
Both TSH and Free T4 are low. In a patient with prior transsphenoidal resection, this indicates central hypothyroidism where she is under-replaced.
TSH is unreliable in pituitary disease; the low Free T4 dictates management (she needs more levothyroxine, not less).

Key Concept

Patients presenting with a depressive episode must be screened for a history of mania/hypomania; Bipolar depression requires mood-stabilizing agents (e.g., quetiapine) rather than SSRI monotherapy, and concurrent use of multiple serotonergic agents (like St. John's wort) must be avoided.
Estimated Time:1m 30s
Question 88Question →

Evaluate the following clinical scenarios of patients presenting with depressive symptoms. Match each patient's clinical presentation with the most suitable treatment modality based on their specific features and comorbidities.

Click a left item, then click its matching right item

Items

A 22-year-old man with a current severe depressive episode. His history includes a distinct 5-day period of elevated mood, decreased need for sleep, and excessive spending.
A 34-year-old man seeking treatment for low energy and poor concentration. He smokes a pack of cigarettes daily and requests a medication that aids in smoking cessation while avoiding sexual side effects.
A 78-year-old woman hospitalized for severe dehydration secondary to depression with delusions of poverty. She is mute and refuses all oral intake.
A 52-year-old man with pervasive sadness and anhedonia, alongside poorly controlled type 2 diabetes mellitus complicated by bilateral burning foot pain.

Matches

Show answer & explanation

Answer

The correct pairings match each patient's specific clinical features and comorbidities with the targeted therapeutic profile of the intervention.
Each clinical scenario presents a patient with depressive symptoms complicated by specific features or comorbidities. Quetiapine is appropriate for bipolar depression. Bupropion addresses both depression and tobacco use without sexual side effects. Electroconvulsive therapy is the treatment of choice for depression with life-threatening food refusal and psychosis. Duloxetine simultaneously targets both depression and painful diabetic neuropathy.

Step-by-Step Solution

1
Identify the diagnosis and treatment needs for the 22-year-old man.
Diagnosis is bipolar II disorder, currently depressed.
The history of a 5-day hypomanic episode precludes a diagnosis of unipolar depression and necessitates treatment with a mood stabilizer or atypical antipsychotic like quetiapine.
2
Analyze the specific preferences and comorbidities of the 34-year-old man.
Requires treatment for depression that also aids in smoking cessation and lacks sexual side effects.
Bupropion meets all these specific criteria due to its dopaminergic and noradrenergic activity without serotonergic sexual side effects.
3
Evaluate the acuity and severity of the 78-year-old woman's presentation.
Major depressive disorder with psychotic features and life-threatening food refusal.
Electroconvulsive therapy provides the rapid, definitive response required for life-threatening inanition and psychosis.
4
Assess the medical comorbidities of the 52-year-old man.
Major depressive disorder with concurrent painful diabetic neuropathy.
Duloxetine is indicated for both depression and neuropathic pain, offering dual benefit.

Key Concept

Individualizing treatment for depressive disorders based on comorbidities, symptom severity, and specific patient preferences.
Question 89Question →

A 68-year-old woman is evaluated in the outpatient clinic for an acute episode of major depressive disorder without psychotic features. Over the course of the next year, her condition proves highly resistant to standard therapies, eventually culminating in severe clinical deterioration. Arrange the following clinical management steps in the correct evidence-based chronological sequence, reflecting the standard escalation of psychiatric care from initial presentation to the eventual onset of life-threatening psychotic depression with severe food refusal.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence of management is: 1. Initiate first-line monotherapy with an SSRI; 2. Switch to a different antidepressant class (e.g., SNRI) after 6 weeks of non-response; 3. Augment the regimen with a second-generation antipsychotic after a partial response; 4. Admit to an acute inpatient psychiatric unit due to new-onset delusions and food refusal; 5. Initiate a course of electroconvulsive therapy (ECT).
The sequence accurately reflects standard USMLE algorithms for escalating depression treatment. Initially, an SSRI is the preferred first-line agent. Complete non-response after an adequate 4-6 week trial prompts a switch to a different agent (e.g., SNRI). If the second agent provides a partial therapeutic response, augmentation (e.g., with aripiprazole or lithium) is appropriate to maximize benefit. If the patient's condition continues to worsen to the point of developing psychotic features or refusing food, outpatient management becomes inherently unsafe, mandating immediate inpatient psychiatric admission. Finally, in the setting of severe psychotic depression with life-threatening food refusal, ECT is the most rapid and effective definitive intervention.

Step-by-Step Solution

1
Establish first-line treatment for an initial major depressive episode.
Initiate SSRI monotherapy.
SSRIs offer the best balance of efficacy and tolerability for initial outpatient treatment.
2
Address complete non-response at 6 weeks.
Switch to an SNRI.
A 4-6 week duration is an adequate trial. Complete absence of clinical improvement dictates switching to a different medication rather than augmenting.
3
Address partial response to the second antidepressant agent.
Augment with a second-generation antipsychotic.
Augmentation builds upon the partial efficacy achieved, avoiding the loss of gained therapeutic benefits that might occur with another switch.
4
Respond to acute safety risks and clinical decompensation.
Inpatient psychiatric admission.
The new onset of psychosis and food refusal poses an imminent threat to the patient's life, requiring a secure hospital setting for immediate stabilization.
5
Select definitive treatment for life-threatening psychotic depression.
Administer ECT.
ECT provides unmatched speed and efficacy for severe, refractory, or psychotic depression, especially when nutritional status is acutely compromised.

Key Concept

Stepped-care pharmacological management of Major Depressive Disorder (MDD) and indications for Electroconvulsive Therapy (ECT)
Estimated Time:1m 30s
Question 90Question →

A 29-year-old woman, G1P0, at 28 weeks gestation is evaluated in the outpatient clinic due to worsening sadness and exhaustion. For the past six weeks, she has felt 'overwhelmed and hopeless,' crying daily. She reports profound despondency that is characteristically worse in the morning, complete loss of appetite, and terminal insomnia, waking up at 3:00 AM and unable to return to sleep. She recently developed an upper respiratory infection and frequently takes over-the-counter dextromethorphan for a persistent cough. Her physical examination is unremarkable. Laboratory studies show a hemoglobin level of 10.810.8 g/dL and a mean corpuscular volume of 8989 μ\mu m 3^3. She asks the physician to prescribe an antidepressant medication to help her cope. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Elicit a history regarding past periods of decreased need for sleep and unusually elevated energy

Answer

The most appropriate next step is to elicit a history regarding past periods of decreased need for sleep and unusually elevated energy.
The correct answer is to elicit a history regarding past periods of decreased need for sleep and unusually elevated energy. This patient is presenting with a major depressive episode with melancholic features. Before initiating any antidepressant therapy, it is mandatory to screen all patients for a history of manic or hypomanic episodes. Antidepressant monotherapy in a patient with undiagnosed bipolar disorder can precipitate a manic or hypomanic episode (manic switch). The peripartum period is a particularly high-risk timeframe for the onset or exacerbation of bipolar disorder.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient presents with symptoms of a major depressive episode with melancholic features during the peripartum period.
To establish the primary psychiatric syndrome requiring evaluation and intervention.
2
Identify the critical preliminary evaluation required before treating depression.
Before prescribing any antidepressant therapy, the patient must be screened for a history of mania or hypomania.
Antidepressants can trigger a manic switch in patients with underlying bipolar disorder. This is particularly crucial in the peripartum period, which is a high-risk time for bipolar affective episodes.
3
Evaluate the distracting options against the patient's history and laboratory values.
Options involving immediate antidepressant monotherapy without screening are incorrect. Furthermore, prescribing phenelzine risks a dangerous interaction with dextromethorphan, and treating her hemoglobin level of 10.810.8 g/dL is unnecessary as it reflects normal dilutional anemia of pregnancy.
To confidently eliminate incorrect management choices by applying pharmacological and physiological knowledge.

Key Concept

Screening for bipolar disorder is mandatory before initiating antidepressant therapy in patients presenting with a major depressive episode to prevent antidepressant-induced manic switch.
Question 91Question →

A 47-year-old male accountant presents to an outpatient psychiatric clinic with a 3-month history of pervasive sadness, anhedonia, terminal insomnia, profound fatigue, impaired concentration, and a 12-lb (5.4 kg) weight loss. He is diagnosed with a severe episode of major depressive disorder without psychotic features. Over the next 14 months, his condition proves remarkably difficult to treat, eventually culminating in a hospitalization for depressive stupor and mood-congruent delusions.

Arrange the following therapeutic interventions in the most appropriate chronological sequence according to standard stepped-care escalation algorithms for major depressive disorder.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for the stepped-care management of major depressive disorder is: 1) Initiation of an SSRI, 2) Cross-tapering to an SNRI after monotherapy failure, 3) Augmentation with a second-generation antipsychotic after multiple monotherapy failures, and 4) Electroconvulsive therapy for treatment-refractory depression with the emergence of psychotic features.
Stepped-care for major depressive disorder begins with a single first-line agent, typically an SSRI. If this fails, the next step is switching to an alternative monotherapy, such as an SNRI or an atypical antidepressant (e.g., bupropion). If the patient remains resistant after multiple monotherapy trials, augmentation strategies are employed (e.g., adding a second-generation antipsychotic, lithium, or T3). Finally, for severe treatment-resistant depression—or when life-threatening complications like depressive stupor or psychotic features arise—electroconvulsive therapy (ECT) becomes the treatment of choice.

Step-by-Step Solution

1
Identify the standard first-line treatment for a new diagnosis of major depressive disorder.
Initiation of an SSRI (citalopram) is placed first in the sequence.
SSRIs have a favorable side-effect profile and are the gold standard for initial outpatient management.
2
Determine the next step when the initial first-line therapy fails to produce remission.
Cross-tapering to an SNRI (duloxetine) is placed second.
Switching monotherapies within or across classes is generally preferred before moving to polypharmacy in order to minimize medication burden.
3
Determine the strategy for a patient who has now failed multiple trials of monotherapy.
Augmentation therapy with a second-generation antipsychotic (aripiprazole) is placed third.
Once multiple monotherapies have failed, adding an augmenting agent is the next evidence-based step for treatment-resistant depression.
4
Identify the ultimate intervention for highly refractory disease, especially when complicated by psychosis or stupor.
Electroconvulsive therapy (ECT) is placed last in the sequence.
The patient eventually developed depressive stupor and mood-congruent delusions, which are primary indications for ECT in severe, refractory cases.

Key Concept

Stepped-care escalation for treatment-resistant major depressive disorder
Estimated Time:1m 0s
Question 92Question →

A 2323-year-old woman presents to the outpatient psychiatric clinic with a 22-month history of profound sadness, fatigue, and social withdrawal. She reports sleeping up to 1414 hours a day and experiencing a strong craving for carbohydrate-rich foods, leading to a 55-kg (1111-lb) weight gain. She states her arms and legs frequently feel "so heavy, it is as if my bones have turned to solid stone." Despite her depressed mood, she notes that she felt briefly happy and energized last week when she received a good grade on an exam, though the low mood quickly returned. She also reports occasionally hearing a voice calling her name just as she is drifting off to sleep. She has no chronic medical conditions. Vital signs are within normal limits. Laboratory studies reveal a thyroid-stimulating hormone (TSH) level of 1.8 \muU/mL1.8 \text{ \mu U/mL} (normal 0.5−5.0 \muU/mL0.5-5.0 \text{ \mu U/mL}) and free thyroxine (T4) of 1.2 ng/dL1.2 \text{ ng/dL} (normal 0.9−1.7 ng/dL0.9-1.7 \text{ ng/dL}). She is currently not taking any medications. She requests an antidepressant to help her focus on her studies. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Elicit a history of periods characterized by elevated mood, decreased need for sleep, and impulsivity

Answer

Eliciting a history of periods characterized by elevated mood, decreased need for sleep, and impulsivity.
The correct response describes the process of screening for a history of manic or hypomanic episodes. This patient is experiencing a major depressive episode with atypical features (mood reactivity, hypersomnia, weight gain, leaden paralysis). Atypical features are highly prevalent in patients with bipolar depression. According to standard psychiatric guidelines, clinicians must explicitly rule out a lifetime history of mania or hypomania before initiating antidepressant monotherapy in any patient presenting with depression. Failure to do so can precipitate a manic switch, which is a psychiatric emergency.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient exhibits depressed mood, hypersomnia, hyperphagia, leaden paralysis (heavy limbs), and mood reactivity (brightening of mood in response to positive events).
Identifying the specific symptom cluster is necessary to classify the depressive subtype.
2
Establish the specific psychiatric syndrome.
The symptoms fulfill the DSM-5 criteria for a major depressive episode with atypical features.
Atypical features have distinct clinical implications, particularly a strong association with bipolar disorder.
3
Evaluate the reported hallucinations and laboratory findings.
The hallucinations occur only while falling asleep (hypnagogic) and are a normal physiological variant, ruling out a primary psychotic disorder. The TSH and T4 levels are normal, ruling out thyroid dysfunction.
It is necessary to exclude medical causes of depression and comorbid primary psychotic disorders before finalizing the management plan.
4
Determine the safest next step in management.
Before starting any antidepressant therapy, the clinician must screen for a history of manic or hypomanic episodes.
Prescribing an antidepressant (like an SSRI) to a patient with unrecognized bipolar disorder can precipitate a severe manic episode. Screening is mandatory.

Key Concept

Prior to initiating antidepressant therapy for a major depressive episode, clinicians must screen for a lifetime history of manic or hypomanic episodes to rule out bipolar disorder and prevent antidepressant-induced mania.
Estimated Time:1m 30s
Question 93Question →

A 42-year-old man is evaluated in the psychiatric clinic for a six-week history of pervasive sadness, insomnia, low energy, and feelings of worthlessness. He frequently thinks about death but has no active suicidal plan. Vital signs and physical examination are unremarkable. Routine laboratory studies, including thyroid function tests, are within normal limits. During the interview, the patient mentions that in his late twenties, he had a one-week period where he slept only two hours a night, felt extremely energetic, and took out multiple unapproved bank loans for a 'revolutionary' business idea. He was hospitalized during that episode. He is currently taking no medications. What is the most appropriate next step in pharmacological management for this patient?

Show answer & explanation

Answer: Quetiapine

Answer

Quetiapine
The patient's current presentation of severe depression, combined with a history of a manic episode requiring hospitalization (decreased need for sleep, grandiosity, impulsivity), solidifies the diagnosis of bipolar I disorder, currently in a depressed episode. The treatment of bipolar depression differs significantly from unipolar depression. First-line pharmacological options for acute bipolar depression include second-generation antipsychotics such as quetiapine, lurasidone, and cariprazine, as well as the olanzapine-fluoxetine combination. Quetiapine has proven efficacy in rapidly alleviating depressive symptoms in bipolar disorder without carrying a high risk of inducing mania.

Step-by-Step Solution

1
Identify the patient's current clinical syndrome.
Major depressive episode.
The patient presents with a six-week history of depressed mood, insomnia, anergia, and passive suicidal ideation.
2
Evaluate the past psychiatric history for prior mood episodes.
History of a severe manic episode requiring hospitalization.
The patient experienced a one-week period of decreased need for sleep, grandiosity, and impulsive behavior leading to hospitalization, which definitively meets criteria for a manic episode.
3
Select the most appropriate pharmacological treatment based on the combined history.
Quetiapine is selected.
The diagnosis is bipolar I disorder, current episode depressed. Quetiapine is a first-line monotherapy for acute bipolar depression that avoids the risk of inducing a manic switch.

Key Concept

Pharmacological management of acute bipolar depression
Estimated Time:1m 15s
Question 94Question →

A 31-year-old woman, G1P1, comes to the outpatient clinic 6 weeks after an uncomplicated vaginal delivery. She is accompanied by her husband, who is concerned about her behavior. For the past 4 weeks, she has experienced profound sadness, frequent crying spells, and a pervasive sense of guilt regarding her parenting. She reports waking up at 3 AM daily and being unable to return to sleep, even when her infant is sleeping. She describes her mood as consistently worse in the mornings and notes no improvement in her mood even when playing with her newborn or when her parents visit. She lacks the energy to perform basic household tasks. She denies suicidal ideation or thoughts of harming the infant. She recalls experiencing a period of "severe depression" in her early twenties that lasted for several months but resolved without treatment. She is currently breastfeeding and takes prenatal vitamins. She does not use tobacco, alcohol, or illicit substances. Vital signs are within normal limits. Which of the following is the most appropriate next step in the evaluation or management of this patient?

Show answer & explanation

Answer: Inquire about a history of persistently elevated mood and decreased need for sleep

Answer

The most appropriate next step is to inquire about a history of persistently elevated mood and decreased need for sleep to screen for bipolar disorder before initiating antidepressant therapy.
The correct action is to inquire about a history of persistently elevated mood and decreased need for sleep. This patient presents with a major depressive episode (MDE) with melancholic features (early morning awakenings, worse mood in the morning, lack of mood reactivity) in the postpartum period. While she requires treatment, the critical next step before prescribing any antidepressant is to screen for a history of manic or hypomanic episodes. A significant proportion of patients presenting with an MDE actually have bipolar disorder. Initiating antidepressant monotherapy (such as an SSRI) in a patient with unrecognized bipolar disorder carries a high risk of precipitating a manic switch. Her history of an untreated 'severe depression' in her early twenties further increases her risk for bipolar disorder.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient meets the criteria for a major depressive episode with melancholic features, occurring in the postpartum period.
Accurate syndrome identification is required to guide further evaluation and treatment.
2
Evaluate the differential diagnosis for postpartum mood changes.
The duration (4 weeks) and severity of symptoms, including neurovegetative signs, rule out self-limited postpartum blues. The fulfillment of major depressive episode criteria rules out adjustment disorder.
Differentiating between normal physiologic changes and pathologic mood disorders ensures appropriate intervention.
3
Determine the necessary safety and diagnostic steps before treatment.
The patient must be screened for a history of manic or hypomanic episodes.
Initiating antidepressant monotherapy in a patient with a history of bipolar disorder (which is strongly suggested by her prior severe depressive episode in her twenties) risks precipitating a manic switch.

Key Concept

Before initiating antidepressant therapy for a major depressive episode, clinicians must screen for a history of manic or hypomanic episodes to prevent antidepressant-induced mania, particularly in patients presenting with a history of untreated depression.
Estimated Time:1m 30s
Question 95Question →

A psychiatric consult service is reviewing the charts of four newly evaluated patients who present with prominent depressive symptoms. Each patient's presentation requires a distinct pharmacological or procedural approach. Match each patient's clinical profile with the most appropriate next step in management or treatment strategy.

Click a left item, then click its matching right item

Items

52-year-old male with a 4-week history of profound sadness, anhedonia, and the fixed false belief that he is single-handedly responsible for an impending global financial collapse.
26-year-old female with a 6-week history of severe low mood, hypersomnia, weight gain, and extreme sensitivity to interpersonal rejection. She reports her limbs feel 'heavy like lead'.
34-year-old female with major depressive disorder who reports persistent daytime fatigue and poor concentration despite 8 weeks of adherence to maximum-dose fluoxetine. She has no history of seizures or eating disorders.
21-year-old male evaluated for severe depressive symptoms. His medical record reveals a psychiatric hospitalization two years ago for acute agitation, grandiosity, and a significantly decreased need for sleep.

Matches

Show answer & explanation

Answer

The clinical profiles map to major depressive disorder (MDD) with psychotic features, MDD with atypical features, SSRI-resistant MDD requiring augmentation, and bipolar I disorder currently in a depressive episode, respectively.
Matching these clinical profiles requires correctly identifying specific depressive disorder subtypes and bipolar depression, each of which has distinct evidence-based pharmacological guidelines that deviate from simple SSRI monotherapy.

Step-by-Step Solution

1
Analyze the first patient's presentation.
Identified mood-congruent delusions (responsibility for global collapse) complicating MDD.
Recognizing psychotic features dictates the need for combined antidepressant and antipsychotic therapy, or ECT.
2
Analyze the second patient's presentation.
Identified reverse vegetative symptoms (hypersomnia, weight gain) and leaden paralysis.
These define MDD with atypical features, which responds well to SSRIs initially, with MAOIs reserved for refractory cases.
3
Analyze the third patient's presentation.
Identified a partial response to optimized SSRI therapy with residual fatigue and cognitive slowing.
Residual symptoms of fatigue and low energy are effectively targeted by augmenting the regimen with a dopamine/norepinephrine-promoting agent like bupropion.
4
Analyze the fourth patient's presentation.
Identified current depressive symptoms in the context of a past manic episode.
A history of mania changes the diagnosis to bipolar depression, which necessitates mood stabilizers and absolute avoidance of antidepressant monotherapy.

Key Concept

Tailoring pharmacotherapy and interventions for specific depressive disorder subtypes and related conditions.
Question 96Question →

Match each patient's clinical presentation with the most appropriate next step in management.

Click a left item, then click its matching right item

Items

A 58-year-old man presents with a 4-week history of pervasive sadness, anhedonia, early morning awakenings, and a 10-lb weight loss. These symptoms began shortly after he suffered an uncomplicated acute myocardial infarction. He has no prior psychiatric history.
A 27-year-old woman complains of a 6-week history of severe depression, sleeping 12 hours a day, increased appetite, and feeling like her arms and legs are "made of lead." She casually mentions that during college, she had a 5-day episode where she felt euphoric, needed only 2 hours of sleep a night, and impulsively bought $5,000 worth of designer clothes.
A 32-year-old woman is brought to the emergency department by her husband 3 weeks after giving birth to a healthy term infant. She exhibits a severely depressed mood, psychomotor retardation, and tearfully confesses that she is hearing a voice telling her that her baby is demonically possessed and must be drowned.
A 35-year-old man with major depressive disorder has been treated with escitalopram 20 mg daily for the past 8 weeks. He reports his mood has improved and he is no longer tearful, but he continues to struggle significantly with low energy, poor concentration, and an inability to focus on his work.

Matches

Show answer & explanation

Answer

The post-MI patient requires sertraline; the bipolar II patient requires quetiapine; the postpartum psychotic patient requires inpatient admission; the partial SSRI responder with fatigue requires bupropion augmentation.
Each clinical presentation dictates a specific algorithmic path in managing depressive disorders. Cardiovascular safety dictates sertraline post-MI. A history of hypomania dictates bipolar-specific therapies like quetiapine and contraindicates SSRI monotherapy. Psychosis with risk of harm to a newborn dictates immediate inpatient admission. Residual fatigue on an SSRI dictates bupropion augmentation to target dopamine and norepinephrine.

Step-by-Step Solution

1
Analyze the post-myocardial infarction patient's profile.
Identify uncomplicated major depressive disorder in the context of recent cardiac ischemia.
Cardiac safety is the primary concern when selecting an antidepressant in this population, making sertraline the safest choice.
2
Analyze the 27-year-old woman's profile.
Identify atypical depressive features along with a distinct past episode of hypomania (euphoria, decreased sleep need, impulsivity lasting 5 days).
Recognizing past hypomanic episodes is crucial to diagnose bipolar II disorder and avoid inappropriate, potentially harmful SSRI monotherapy.
3
Analyze the 32-year-old postpartum woman's profile.
Identify severe postpartum depression with psychotic features (command hallucinations to harm the baby).
This represents a psychiatric emergency with a high risk of infanticide, necessitating the highest level of care (inpatient admission) immediately.
4
Analyze the 35-year-old man's profile.
Identify a partial response to an optimized SSRI dose, with residual symptoms specifically in the domains of energy and concentration.
Targeting specific residual symptoms with complementary pharmacologic mechanisms (e.g., increasing norepinephrine and dopamine with bupropion) optimizes remission rates.

Key Concept

Individualizing the management of depressive disorders requires screening for bipolar disorder, assessing for medical comorbidities (e.g., recent myocardial infarction), recognizing psychiatric emergencies (e.g., psychosis with risk of harm), and tailoring pharmacotherapy to residual symptoms.
Estimated Time:2m 0s
Question 97Question →

A 32-year-old woman is evaluated in the outpatient psychiatric clinic for worsening mood. She delivered a healthy full-term infant 2 months ago. For the last 3 weeks, she has experienced profound sadness, anhedonia, loss of appetite resulting in a 3-kg (6.6-lb) weight loss, and extreme guilt about being a "terrible mother." For the past week, she reports hearing a persistent, derogatory voice telling her she should "disappear." Her husband notes that 6 years ago, she had a 3-week period where she abruptly quit her job, slept only 2 hours per night but felt fully energetic, exhibited pressured speech, and maxed out their credit cards. This previous episode required a brief psychiatric hospitalization, but she stopped taking her prescribed medications 5 years ago. She currently takes no medications. Vital signs are within normal limits. On examination, she exhibits a blunted affect and psychomotor retardation. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate quetiapine monotherapy

Answer

The most appropriate next step is to initiate quetiapine monotherapy.
The correct action is to initiate quetiapine monotherapy. This patient is currently experiencing a major depressive episode with psychotic features (auditory hallucinations, profound sadness, guilt, weight loss). However, her history of a distinct episode characterized by a decreased need for sleep, pressured speech, impulsivity, and hospitalization definitively indicates a past manic episode. Therefore, her underlying diagnosis is bipolar I disorder, and she is currently experiencing bipolar depression with psychotic features. Quetiapine is an atypical antipsychotic that is FDA-approved for bipolar depression; it will simultaneously target both her severe mood symptoms and her psychotic features without carrying the risk of inducing a manic switch.

Step-by-Step Solution

1
Identify the current clinical syndrome from the presentation.
The patient has a 3-week history of severe depressive symptoms and a 1-week history of auditory hallucinations, indicating a major depressive episode with psychotic features.
Characterizing the current episode is necessary before determining the overarching psychiatric diagnosis.
2
Review the patient's psychiatric history for previous mood episodes.
The patient had a distinct 3-week episode of decreased need for sleep, pressured speech, and reckless behavior requiring hospitalization.
A history of a manic episode changes the diagnosis from unipolar major depressive disorder to bipolar I disorder.
3
Formulate the correct comprehensive diagnosis.
The diagnosis is bipolar I disorder, currently in a depressive phase with psychotic features, with postpartum onset.
Accurate diagnosis prevents the use of contraindicated medications like SSRI monotherapy.
4
Select the appropriate pharmacological treatment.
Quetiapine is chosen as the next step in management.
Bipolar depression with psychotic features requires an agent that provides mood stabilization and antipsychotic effects. Quetiapine is an atypical antipsychotic approved for bipolar depression.

Key Concept

Discrimination between unipolar and bipolar depression with psychotic features, and selection of appropriate mood-stabilizing pharmacotherapy.
Question 98Question →

Review the clinical vignettes below, representing adult patients currently undergoing psychiatric evaluation for mood symptoms. Map each individual's unique presentation to the most appropriate initial pharmacological or procedural intervention.

Click a left item, then click its matching right item

Items

A 42-year-old man hospitalized for profound despair, psychomotor agitation, and mood-congruent auditory hallucinations telling him he is 'corrupted from the inside.' He is medically stable, cooperative with nursing staff, and eating adequately.
A 68-year-old man transferred from an assisted living facility due to a 10-day history of mutism, stupor, and absolute refusal to ingest food or fluids, which has now resulted in acute prerenal azotemia and severe dehydration.
A 24-year-old woman with a two-month history of sleeping 14 hours daily, intense carbohydrate cravings, weight gain, and 'leaden' fatigue. She strongly desires medication but specifically requests an option that avoids sexual side effects.
A 28-year-old woman presenting 4 weeks after an uncomplicated vaginal delivery with pervasive anhedonia, insomnia despite infant sleep, and extreme tearfulness. She is exclusively breastfeeding her newborn infant.

Matches

Show answer & explanation

Answer

The correct pairings map the medically stable psychotic depression to combined antidepressant/antipsychotic therapy; the life-threatening catatonic depression to ECT; the atypical depression with sexual side-effect concerns to bupropion; and the postpartum depression in a lactating mother to sertraline.
Each correct match strictly aligns with psychiatric treatment guidelines: psychotic features require dual therapy (antidepressant + antipsychotic); severe medical compromise (starvation/dehydration) mandates the rapid, definitive efficacy of ECT; atypical symptoms with an aversion to sexual dysfunction perfectly fit the profile for bupropion; and lactation requires medications with negligible breast milk excretion, like sertraline.

Step-by-Step Solution

1
Analyze each patient's presenting symptoms to identify the specific depressive subtype or modifying clinical circumstance.
Identified psychotic features, life-threatening catatonia, atypical features with specific side-effect requests, and the postpartum/lactating state.
Major depressive disorder is heterogeneous; treatment choice heavily relies on recognizing these specific modifiers.
2
Select the evidence-based first-line treatment corresponding to each clinical modifier.
Matched each presentation to its respective guideline-directed therapy (e.g., ECT for acute life-threatening situations, Sertraline for lactation safety).
Ensures the chosen intervention maximizes efficacy while minimizing harm for the specific demographic or symptomatic presentation.

Key Concept

Treatment selection for major depressive disorder subtypes and special populations
Estimated Time:1m 30s
Question 99Question →

A 50-year-old woman is diagnosed with major depressive disorder following a period of persistent low mood and anhedonia. Over the next year, her condition progressively worsens despite various treatment attempts, culminating in a state of severe melancholia characterized by a life-threatening refusal to eat and drink. Arrange the following clinical management steps in the correct chronological sequence, representing a standard stepped-care escalation for this patient's evolving clinical condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first initiate SSRI monotherapy, then maximize the dosage of that initial agent, followed by augmenting or switching the medication if response remains poor, and finally administering ECT when life-threatening symptoms emerge.
The stepped-care algorithm for major depressive disorder dictates a sequential escalation of therapies based on clinical response. Treatment begins with an initial trial of an SSRI. If the patient has a sub-optimal response, the immediate next step is to maximize the dose of the current medication to ensure an adequate therapeutic trial. Only after failure of an optimized trial should the clinician proceed to augment the regimen (e.g., with an atypical antipsychotic) or switch to a different class. Ultimately, the development of life-threatening complications, such as the refusal to eat and drink leading to severe physiological compromise, is a primary indication for urgently escalating to electroconvulsive therapy (ECT).

Step-by-Step Solution

1
Identify the first-line treatment for a new diagnosis of major depressive disorder.
Initiate SSRI monotherapy.
SSRIs are standard initial therapy due to their favorable side-effect profile and established efficacy.
2
Determine the next step if the initial clinical response is inadequate.
Maximize the dosage of the initial SSRI.
An adequate trial requires optimization of the dose and a sufficient duration (4-8 weeks) before declaring treatment failure.
3
Determine the management for continued non-response or partial response after dose optimization.
Augment the regimen with an atypical antipsychotic or switch classes.
When a maximized first-line agent fails, standard algorithms recommend augmentation strategies or switching to alternative agents like SNRIs or bupropion.
4
Identify the definitive treatment for severe, treatment-resistant depression with life-threatening features.
Administer electroconvulsive therapy (ECT).
ECT provides the most rapid and effective response for severe depression complicated by refusal to eat, catatonia, or acute suicidality.

Key Concept

Stepped-care pharmacological escalation and indications for ECT in Major Depressive Disorder
Estimated Time:1m 0s
Question 100Question →

A 28-year-old man presents to a primary care clinic with a 2-month history of worsening mood, severe fatigue, and lack of motivation. He reports sleeping up to 12 hours a day but still feeling exhausted upon waking. Additionally, he has experienced a significant increase in appetite, resulting in a 6 kg (13.2 lb) weight gain over the past month. He describes a pervasive sensation of extreme heaviness in his arms and legs, making it difficult to get out of bed. His past medical history is notable for a severe depressive episode at age 20. At that time, he was prescribed a medication that he discontinued after 3 weeks because it made him feel "too wired and agitated." He is currently not taking any medications. Vital signs and physical examination are unremarkable. The physician is considering starting an antidepressant. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Inquire about periods of excessive energy, racing thoughts, and decreased need for sleep

Answer

The most appropriate next step is to inquire about periods of excessive energy, racing thoughts, and decreased need for sleep to rule out bipolar disorder.
The correct approach is to inquire about periods of excessive energy, racing thoughts, and decreased need for sleep. This patient presents with a major depressive episode characterized by atypical features (hypersomnia, hyperphagia, weight gain, and leaden paralysis). A crucial red flag in his history is the 'wired and agitated' reaction to a previously prescribed medication (likely an antidepressant). This adverse reaction, combined with early-onset depression and atypical features, is highly suggestive of bipolar disorder. Standard medical guidelines require that all patients presenting with a depressive episode be screened for a history of mania or hypomania before initiating antidepressant therapy to prevent an iatrogenic manic switch.

Step-by-Step Solution

1
Identify the primary symptom cluster.
The patient presents with hypersomnia, hyperphagia, weight gain, and leaden paralysis (heavy limbs) alongside low mood.
These symptoms define major depressive disorder with atypical features.
2
Analyze historical red flags.
The patient had a previous severe depressive episode at age 20 and experienced a 'wired and agitated' reaction to a prescribed medication.
Early onset of depression, atypical features, and activation/agitation on antidepressants are strong indicators of an underlying bipolar spectrum disorder.
3
Determine the necessary clinical action before treatment.
The physician must screen for a lifetime history of manic or hypomanic episodes.
Prescribing antidepressant monotherapy to a patient with bipolar disorder can precipitate a manic switch. It is critical to confirm whether the depressive disorder is unipolar or bipolar before initiating pharmacotherapy.

Key Concept

All patients presenting with a depressive episode must be screened for a lifetime history of mania or hypomania to rule out bipolar disorder prior to initiating antidepressant monotherapy. This is especially critical in patients with atypical features or a history of antidepressant-induced activation.
Estimated Time:1m 0s
PreviousPage 5 / 6Next
Depressive Disorders Practice Questions — USMLE Step 2 CK — Page 5 | Examkin